Skip to main content
Log in

Delay in diagnosis and outcome of Acanthamoeba keratitis

  • Clinical Investigation
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To evaluate the outcome of Acanthamoeba keratitis with respect to the delay in diagnosis.

Methods

A retrospective review of the records of 14 patients treated for Acanthamoeba keratitis was carried out. Delay in diagnosis was correlated with risk factors, clinical presentation, method of diagnosis, final visual acuity and need for penetrating keratoplasty.

Results

Based on the time interval between the first symptoms and the diagnosis of Acanthamoeba keratitis, it appeared that patients could be divided into two groups: an early treatment group (group I), consisting of six patients treated within 18 days of onset of symptoms, and a late treatment group (group II), composed of eight patients treated beyond that time. There were no statistically significant differences between the two groups as far as risk factors, clinical presentation, accuracy of diagnosis and method of diagnosis were concerned, although more extensive and deeper corneal involvement was noted in group II. Improvement in visual acuity following medical therapy was seen in all six patients in the early group and in three (37%) of the eight patients in the late group. One patient in group I needed urgent penetrating keratoplasty for corneal necrosis. In group II, two patients underwent penetrating keratoplasty à chaud to prevent corneal perforation and three patients needed penetrating keratoplasty to restore functional visual acuity.

Conclusion

A diagnostic delay of less than 18 days between onset of symptoms and start of anti-amoebic treatment results in a better final VA after medical treatment and obviates the need for urgent and elective penetrating keratoplasty.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.
Fig. 2.

Similar content being viewed by others

References

  1. Bacon AS, Dart JK, Ficker LA, Matheson MM, Wright P (1993) Acanthamoeba keratitis. The value of early diagnosis. Ophthalmology 100:1238–1243

    CAS  PubMed  Google Scholar 

  2. Bacon AS, Frazer DG, Dart JK, Matheson M, Ficker LA, Wright P (1993) A review of 72 consecutive cases of Acanthamoeba keratitis, 1984–1992. Eye 7 (6):719–725

    PubMed  Google Scholar 

  3. Bialasiewicz AA, Bischoff G, Walter A, Engelmann K, Richard G (2001) [Correlation of 55 samples of contact lens fluid and direct swabbings of the eye surface of symptomatic wearers of contact lenses]. Ophthalmologe 98:747–760

    Article  CAS  PubMed  Google Scholar 

  4. Chynn EW, Lopez MA, Pavan-Langston D, Talamo JH (1995) Acanthamoeba keratitis. Contact lens and noncontact lens characteristics. Ophthalmology 102:1369–1373

    CAS  PubMed  Google Scholar 

  5. Devonshire P, Munro FA, Abernethy C, Clark BJ (1993) Microbial contamination of contact lens cases in the west of Scotland. Br J Ophthalmol 77:41–45

    CAS  PubMed  Google Scholar 

  6. Duguid IG, Dart JK, Morlet N, Allan BD, Matheson M, Ficker L, Tuft S (1997) Outcome of acanthamoeba keratitis treated with polyhexamethyl biguanide and propamidine. Ophthalmology 104:1587–1592

    CAS  PubMed  Google Scholar 

  7. Ficker LA, Kirkness C, Wright P (1993) Prognosis for keratoplasty in Acanthamoeba keratitis. Ophthalmology 100:105–110

    CAS  PubMed  Google Scholar 

  8. Illingworth CD, Cook SD (1996) Acanthamoeba keratitis. Surv Ophthalmol 42:493–508

    Article  Google Scholar 

  9. Illingworth CD, Cook SD, Karabatsas CH, Easty DL (1995) Acanthamoeba keratitis: risk factors and outcome. Br J Ophthalmol 79:1078–1082

    CAS  PubMed  Google Scholar 

  10. Jones DB, Visvesvara GS, Robinson NM (1975) Acanthamoeba polyphaga keratitis and Acanthamoeba uveitis associated with fatal meningoencephalitis. Trans Ophthalmol Soc U K 95:221–232

    CAS  PubMed  Google Scholar 

  11. Kremer I, Cohen EJ, Eagle RC, Udell I, Laibson PR (1994) Histopathologic evaluation of stromal inflammation in Acanthamoeba keratitis. CLAO J 20:45–48

    CAS  PubMed  Google Scholar 

  12. Larkin DF, Kilvington S, Easty DL (1990) Contamination of contact lens storage cases by Acanthamoeba and bacteria. Br J Ophthalmol 74:133–135

    CAS  PubMed  Google Scholar 

  13. Larkin DF, Kilvington S, Dart JK (1992) Treatment of Acanthamoeba keratitis with polyhexamethylene biguanide. Ophthalmology 99:185–191

    CAS  PubMed  Google Scholar 

  14. Lindquist TD (1998) Treatment of Acanthamoeba keratitis. Cornea 17:11–16

    CAS  PubMed  Google Scholar 

  15. Mannis MJ, Tamaru R, Roth AM, Burns M, Thirkill C (1986) Acanthamoeba sclerokeratitis: determing diagnostic criteria. Arch Ophthalmol 104:1313–1317

    CAS  PubMed  Google Scholar 

  16. Mathers WD, Sutphin JE, et al (1996) Outbreak of keratitis presumed to be caused by Acanthamoeba. Am J Ophthalmol 121:129–142

    CAS  PubMed  Google Scholar 

  17. Moore MB, McCulley JP (1989) Acanthamoeba keratitis associated with contact lenses: six consecutive cases of successful management. Br J Ophthalmol 73:271–275

    CAS  PubMed  Google Scholar 

  18. Naginton J, Watson PG, Playfair TJ, McGill J, Jones BR, Steele AD (1974) Amoebic infection of the eye. Lancet 2:1537–1540

    Article  PubMed  Google Scholar 

  19. Radford CF, Bacon AS, Dart JK, Minassian DC (1995) Risk factors for acanthamoeba keratitis in contact lens users: a case-control study. BMJ 310:1567–1570

    CAS  PubMed  Google Scholar 

  20. Radford CF, Minassian DC, Dart JK (2002) Acanthamoeba keratitis in England and Wales: incidence, outcome, and risk factors. Br J Ophthalmol 86:536–542

    Article  CAS  PubMed  Google Scholar 

  21. Schaumberg DA, Snow KK, Dana MR (1998) The epidemic of Acanthamoeba keratitis: where do we stand? Cornea 17:3–10

    CAS  PubMed  Google Scholar 

  22. Seal D, Hay J, Kirkness C, Morrell A, Booth A, Tullo A, Ridgway A, Armstrong M (1996) Successful medical therapy of Acanthamoeba keratitis with topical chlorhexidine and propamidine. Eye 10 (4):413–421

    PubMed  Google Scholar 

  23. Sharma S, Garg P, Rao GN (2000) Patient characteristics, diagnosis, and treatment of non-contact lens related Acanthamoeba keratitis. Br J Ophthalmol 84:1103–1108

    Article  CAS  PubMed  Google Scholar 

  24. Tabin G, Taylor H, Snibson G, Murchison A, Gushchin A, Rogers S (2001) Atypical presentation of Acanthamoeba keratitis. Cornea 20:757–759

    Article  CAS  PubMed  Google Scholar 

  25. Wright P, Warhurst D, Jones BR (1985) Acanthamoeba keratitis successfully treated medically. Br J Ophthalmol 69:778–782

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Claerhout.

Additional information

Ilse Claerhout is a research assistant of the Flemish Fund for Scientific Research (FWO-Vlaanderen), Belgium

Rights and permissions

Reprints and permissions

About this article

Cite this article

Claerhout, I., Goegebuer, A., Van Den Broecke, C. et al. Delay in diagnosis and outcome of Acanthamoeba keratitis. Graefe's Arch Clin Exp Ophthalmol 242, 648–653 (2004). https://doi.org/10.1007/s00417-003-0805-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-003-0805-7

Keywords

Navigation